MURATA, S.; NAKAMURA, M.; SUGIHARA, K.; SAKAI, T.; ISHIOKA, K.; TAKAHASHI, S.; SASADA, S.; YASUDA, H.; FUKUNAGA, K. The Change in Neutrophil-to-lymphocyte Ratio after Initiation of Nivolumab Monotherapy May be a Strong Marker of Response and Predictor of Prognosis in Advanced Non-small Cell Lung Carcinoma. Asian Pacific Journal of Cancer Care, v. 7, n. 1, p. 191-196, 8 mar. 2022.